Skip to main content

Table 1 Clinical and pathological parameters of the radiosensitivity and radioresistance groups

From: Exosomes overexpressing miR-34c inhibit malignant behavior and reverse the radioresistance of nasopharyngeal carcinoma

Classification

Radioresistance group (n = 41)

Radiosensitivity group (n = 29)

P*

Sex

 Male

35

23

0.752

 Female

6

6

Age

 <50

28

20

1.000

 ≥50

13

8

KPS

90.00 ± 0.01

89.71 ± 1.69

0.321

Pathologic type

 Differentiated

8

5

1.000

 Undifferentiated

33

24

Clinical stage

   

 I

0

0

0.883

 II

6

5

 III

14

11

 Iva + IVb

21

13

T stage

 T1

2

2

0.693

 T2

6

4

 T3

15

13

 T4

18

10

N stage

 N0

1

0

0.694

 N1

16

13

 N2

21

13

 N3

3

3

Hemoglobin (g/l)

137.6 ± 15.5

139.8 ± 17.7

0.577

PGTVnx

71.99 ± 1.14

71.77 ± 1.18

0.437

PGTVnd

68.88 ± 2.15

68.20 ± 2.64

0.243

CTV1

60.74 ± 0.98

60.80 ± 0.99

0.809

CTV2

54.72 ± 0.87

54.77 ± 0.90

0.809

  1. * There was no significant difference between the 2 groups